• 1
    Andrykowski MA, Curran SL, Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med. 1998; 21: 1-18.
  • 2
    Servaes P, Gielissen MFM, Verghagen S, Bleijenberg G. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology. 2007; 16: 787-795.
  • 3
    Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates, and interventions. Eur J Cancer. 2002; 38: 27-43.
  • 4
    Stone PC, Minton O. Cancer-related fatigue. Eur J Cancer. 2008; 44: 1097-1104.
  • 5
    Cella D, Peterman A, Passik S, et al. Progress toward guidelines for the management of fatigue. Oncology (Williston Park). 1998; 12: 369-377.
  • 6
    Sadler IJ, Jacobsen PB, Booth-Jones M, et al. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage. 2002; 23: 406-416.
  • 7
    Andrykowski MA, Schmidt JE, Salsman JM, et al. Use of a case definition approach to identifying cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 2005; 23: 6613-6622.
  • 8
    Cella D, Davis K, Breitbart W, et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001; 19: 3385-3391.
  • 9
    Young KE, White CA. The prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res. 2006; 60: 29-38.
  • 10
    Alexander S, Minton O, Stone P. Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. J Clin Oncol. 2009; 27: 1197-1201.
  • 11
    Alexander S, Minton O, Andrews P, Stone P. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer. 2009; 45: 384-392.
  • 12
    Fernandes R, Stone P, Andrews P, Morgan R, Sharma S. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. J Pain Symptom Manage. 2006; 32: 245-254.
  • 13
    Murphy H, Alexander S, Stone P. Investigation of diagnostic criteria for cancer-related fatigue syndrome in patients with advanced cancer: a feasibility study. Palliat Med. 2006; 20: 413-418.
  • 14
    Jacobsen PB, Donovan KA, Small BJ, Jim HS, Munster PN, Andrykowski MA. Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer. 2007; 110: 1851-1859.
  • 15
    Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB. Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer. 2009; 15: 1776-1783.
  • 16
    Katz JN, Chang LC, Sangha O, et al. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996; 34: 73-84.
  • 17
    Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Amer J Epidemiol. 1994; 140: 1091-1095.
  • 18
    Jacobsen PB, Azzarello LM, Hann DM. Relation of catastrophizing to fatigue severity in women with breast cancer. Cancer Res. Ther Control. 1999; 8: 155-164.
  • 19
    Ray C, Weir W, Stewart D, Miller P, Hyde G. Ways of coping with chronic fatigue syndrome: development of an illness management questionnaire. Soc Sci Med. 1993; 37: 385-391.
  • 20
    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992; 30: 473-483.
  • 21
    Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 385-401.
  • 22
    Hann DM, Jacobsen PB, Azzarello LM, et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998; 7: 301-310.
  • 23
    McNair PM, Lorr M, Droppelman L. POMS Manual. 2nd ed. San Diego, CA: Educational and Industrial Testing Service; 1981.
  • 24
    First MB, Gibbons M, Spitzer RL. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders: Research Version. New York: Biometrics Research; 1996.
  • 25
    Hays RD, Wooley JM. The concept of clinically-meaningful differences in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics. 2000; 18: 419-423.
  • 26
    Donovan KA, Small BJ, Andrykowski MA, Munster P, Jacobsen PB. Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol. 2007; 26: 464-472.
  • 27
    Wessely S, Hotopf M, Sharpe M. Chronic Fatigue and Its Syndromes. New York, NY: Oxford University Press; 1998.
  • 28
    Keefe F, Gil K. Behavioral concepts in the analysis of chronic pain syndromes. J Consult Clin Psychol. 1986; 54: 776-783.
  • 29
    Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum. 1998; 25: 51-62.
  • 30
    Mock V, Pickett M, Ropka ME, et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract. 2001; 9: 119-127.
  • 31
    Chambers D, Bagnali A, Hempel S, Forbes C. Interventions for the treatment, management, and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J Roy Soc Med. 2006; 99: 506-520.
  • 32
    Gielissen MF, Verhagen S, Wigjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol. 2006; 24: 4882-4887.
  • 33
    Courneya KS, Mackley JR, Bell GJ, et al. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003; 21: 1660-1669.
  • 34
    National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Cancer-RelatedFatigue (V. 1.2009). NCCN website Accessed on 11/2/2009.